Canadian Guidelines for MS
Treatment optimization in multiple sclerosis
Relapse
Rate
Tap to select
Progression
EDSS score at treatment initiation
If EDSS progression alone is used to assess response to treatment, any change requires subsequent confirmation at 3-6 months.
Timed 25-foot walk
Not performed
MRI findings
Number of new Gd-enhancing lesions OR Number of accumulated new T2 lesions per year
New T2 lesions that are also enhancing on the same scan are only counted once as unique active lesions.
Results
Provide answers for all areas to see result
Ulteriori informazioni
Istruzioni d’uso e bibliografia
Avvertenza
Questo strumento è stato progettato solo per fini educativi e non rappresenta un'alternativa a una consulenza professionale. Lo strumento non deve essere utilizzato per fornire diagnosi mediche e/o stabilire i trattamenti.
Medical advisors
Tool was developed in cooperation with asist. Lina Savšek, MD, Department of neurology, SB Celje and Gregor Brecl Jakob, MD, Department of neurology, UKC Ljubljana.
References
Freedman MS, Selchen D, Arnold DL, et al. Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations. Can J Neurol Sci. 2013; 40: 307-323.
Versione
1
Informazioni su questo strumento
Tool was developed in cooperation with asist. Lina Savšek, MD, Department of neurology, SB Celje and Gregor Brecl Jakob, MD, Department of neurology, UKC Ljubljana.
